Outcomes after hematopoietic cell transplant and gene therapy for adenosine deaminase (ADA) severe combined immune deficiency: A combined analysis from the Primary Immune Deficiency Treatment Consortium (PIDTC) 6901 and 6902 studies Meeting Abstract

  

Authors:	Cuvelier, G. D. E.; Logan, B.; Prockop, S. E.; Buckley, R. H.; Kuo, C. Y.; Griffith, L. M.; Liu, X.; Yip, A.; Hershfield, M. S.; Parrott, R. E.; Ebens, C. L.; Moore, T. B.; O’Reilly, R. J.; Pai, S. Y.; Kapadia, M.; Kapoor, N.; Forbes Satter, L. R.; Martinez. C.; Burroughs, L. M.; Petrovic, A.; Thakar, M. S.; Chellapandian, D.; Heimall, J.; Shyr, D. C.; Rayes, A.; Bednarski, J. J. 2nd; Chandra, S.; Chandrakasan, S.; Gillio, A. P.; Madden, L.; Quigg, T. C.; Caywood, E. H.; Dávila Saldaña, B. J.; DeSantes, K.; Eissa, H.; Goldman, F.; Rozmus, J.; Shah, A. J.; Vander Lugt, m. t.; Pulsipher, M. A.; Notarangelo, L. D.; Cowan, M. J.; Dvorak, C. .C; Haddad, E.; Puck, J.; Kohn, D. B.
Abstract Title:	Outcomes after hematopoietic cell transplant and gene therapy for adenosine deaminase (ADA) severe combined immune deficiency: A combined analysis from the Primary Immune Deficiency Treatment Consortium (PIDTC) 6901 and 6902 studies
Meeting Title:	2022 Tandem Meetings of ASTCT and CIBMTR
Journal Title:	Transplantation and Cellular Therapy
Volume:	28
Issue:	3 Suppl.
Meeting Dates:	2022 Apr 23-26
Meeting Location:	Salt Lake City, UT
ISSN:	2666-6375
Publisher:	Elsevier Inc.
Date Published:	2022-03-01
Start Page:	S100
End Page:	S101
PROVIDER:	manual
DOI:	10.1016/S2666-6367(22)00285-8
Notes:	Meeting Abstract: 124 -- Located within the section named "(PEDS) Best Abstracts Session"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/196978